
In re ACTOS Antitrust Litig.
OPINION & ORDER This case concerns the diabetes medication ACTOS and whether its manufacturer Takeda violated antitrust laws by misdescribing its patent rights to the Food and Drug Administration (the “FDA”), which in turn delayed the introduction of a …